VS
Venkatesan Saravanan
Lantern Pharma, SRM Institute of Science and Technology (Deemed to be University) College of Pharmacy, National Center for High-Performance Computing
0000-0003-3991-3600
Employment
-
National Center for High-Performance Computing International Scholar2023 - 2023
-
Lantern Pharma
-
SRM Institute of Science and Technology (Deemed to be University) College of Pharmacy Research Scholar
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- An In Silico Pharmacophore-driven Virtual Screening and Molecular Docking for Identifying Potential AKT Inhibitors of Natural Origin Save
- Hydroxyl chalcone derivative DK02 as a multi‐target‐directed ligand for Alzheimer's disease: A preclinical study in zebrafish Save
- Furan-based chalcone protects β-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing Peroxisome Proliferator-Activated Receptor agonists (PPAR-γ) signaling Save
- Imidazooxazine moiety as polyketide synthase 13 inhibitors targeting tuberculosis Save
- Dual Anti-Inflammatory and Anticancer Activity of Novel 1,5-Diaryl Pyrazole Derivatives: Molecular Modeling, Synthesis, In Vitro Activity, and Dynamics Study Save
- Discovery and development of COVID‐19 vaccine from laboratory to clinic Save
- Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX Save
- DESIGN AND DEVELOPMENT OF POTENTIAL ANTI-TUBERCULAR LEADS POSSESSING 4-AMINO QUINOLINE MOIETY AS DNA GYRASE B INHIBITORS Save
- An overview of mechanism and chemical inhibitors of shikimate kinase Save
- Design synthesis and biological evaluation of thiophene 2- pentafluoro benzamide derivatives as antitubercular agent Save